Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS

A New Level of Engagement in CPR Training - Laerdal Medical Introduces Little Anne® QCPR


WAPPINGERS FALLS, N.Y., Oct. 18, 2017 /PRNewswire/ -- Achieving student engagement is a fundamental challenge in any form of education ? including Cardiopulmonary Resuscitation (CPR) training. To help improve the classroom experience and learner outcomes, Laerdal Medical has launched the next generation of Little Anne®, which includes Quality-CPR (QCPR) functionality. Today, Laerdal Medical debuted the new manikin at EMS World Expo in Las Vegas, NV.

Learners perform compressions on Little Anne® QCPR while the CPR instructor provides feedback via the Instructor App.

Little Anne® QCPR includes objective feedback and measurement technology to take the guesswork out of instruction. Using Bluetooth Smart technology, Little Anne® QCPR can connect with a feedback application downloaded to a smartphone or tablet. The manikin can be used with an Instructor App, which provides a performance overview and monitoring of up to six manikins at once, and a Learner App, which allows students to monitor their own individual performance. Both apps are free downloads. Little Anne® QCPR can also provide feedback via a tethered SkillGuide device.

This newly-enhanced manikin helps increase training efficiency and effectiveness, while the feedback and scoring help to increase learner engagement and confidence. Key features include:

Existing Little Anne manikins can be upgraded to QCPR using the Little Anne QCPR Upgrade Kit, which is a quick and simple upgrade that can be performed by the customer.

"Laerdal has been committed to developing high-quality CPR training solutions since Resusci Anne was introduced in 1960.  Now, Little Anne QCPR builds on that legacy and brings exciting new "technology-based feedback" to support both CPR Instructors and lay students involved with bystander CPR training," says David Johnson, President, Laerdal Medical, Americas.

To learn more about Little Anne® QCPR, visit www.Laerdal.com/LittleAnneQCPR.

About Laerdal

Laerdal Medical is dedicated to the mission of helping save lives through the advancement of simulation-based training in the fields of resuscitation, patient care, and emergency care training. Laerdal products and programs are used by educational institutions, hospitals, Emergency Medical Services (EMS), and military around the world. For more information, visit www.laerdal.com.

Press Contact

Danica McDonough, Media Relations
Email: [email protected] 
Telephone: (845) 297-7770

 (PRNewsfoto/Laerdal Medical)

SOURCE Laerdal Medical


These press releases may also interest you

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

at 12:06
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...

at 12:05
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...



News published on and distributed by: